Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 10mg | $29.57 | $2.96/mg | In stock | Jul 8 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. BPC-157 is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Sunrise Bioresearch sell BPC-157?
Yes — Sunrise Bioresearch currently lists BPC-157 in 1 variant starting at $29.57 ($2.96/mg).
Is Sunrise Bioresearch's BPC-157 third-party tested?
Yes — Disclosed Labs has indexed 6 Certificates of Analysis for Sunrise Bioresearch's BPC-157, with the most recent showing 99.8% purity. Sunrise Bioresearch holds an overall trust grade of A (93/100) across all 54 COAs on file.
What is Sunrise Bioresearch's trust grade for BPC-157?
Sunrise Bioresearch has an overall Disclosed Labs trust grade of A (93/100), computed from 54 COAs across all peptides. The most recent BPC-157 COA was issued by ILS Labs.
Where is the cheapest BPC-157?
As of the latest data, Alpha Peptides offers BPC-157 at $1.82/mg — compare with Sunrise Bioresearch's listing at $2.96/mg. See the full BPC-157 price comparison.
Is BPC-157 legal to buy?
BPC-157 is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| BPC10MAY26-02 | May 2026 | 99.3% | ILS Labs | Endotoxin, Sterility, Heavy metals | Confirmed1 flag | View |
| BPCSEP25-01 | Sep 2025 | 99.5% | Freedom Diagnostics | — | Confirmed | View |
| BPCAUG25-02 | Aug 2025 | 99.2% | Freedom Diagnostics | — | Confirmed | View |
| BPCAUG25-01 | Aug 2025 | 99.0% | Freedom Diagnostics | — | Confirmed | View |
| BPCDEC25-01 | — | 97.8% | Freedom Diagnostics | Endotoxin | Confirmed1 flag | View |
Disclosed Labs